[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:bipolar-depression":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":32,"states":33},"Bipolar Depression",3,1,[8,16,24],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07266545","RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)",[12],"Phase 4","RECRUITING","2026-08-26T02:17:35.666428Z","2026-07-05T04:52:06.752829Z",{"nct_id":17,"title":18,"phases":19,"status":21,"updated_at":22,"content_modified":23},"NCT07217860","An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)",[20],"Phase 3","ENROLLING_BY_INVITATION","2026-08-26T02:16:44.178623Z","2026-06-16T05:54:07.872460Z",{"nct_id":25,"title":26,"phases":27,"status":29,"updated_at":30,"content_modified":31},"NCT03748446","Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder",[28],"Early Phase 1","ACTIVE_NOT_RECRUITING","2026-08-03T03:27:21.703656Z","2026-05-05T02:43:27.493990Z",[],[]]